EP Medsystems Inc Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Lele Abhijeet J, was filed 27 Nov 2006.
EP Medsystems Inc: what insiders have been doing
EP Medsystems Inc is a listed company. Filings by its managers are published through SEC (Form 4). No insider at EP Medsystems Inc has published a filing in the past twelve months. The most recent one dates from 27 November 2006.
Our records for EP Medsystems Inc go back to 2006, with 12 purchases and no sales on the open market in total.
Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
- 2,300 shares@ US$1.28Common stockSEC:0001181431-06-066027:0Canonical exit: 20 Feb 2007 (T+90)
- 200 shares@ US$1.29Common stockSEC:0001181431-06-066027:1Canonical exit: 20 Feb 2007 (T+90)
- 400 shares@ US$1.29Common stockSEC:0001181431-06-066027:2Canonical exit: 20 Feb 2007 (T+90)
- 3,200 shares@ US$1.29Common stockSEC:0001181431-06-066027:3Canonical exit: 20 Feb 2007 (T+90)
- 16,000 shares@ US$1.30Common stockSEC:0001181431-06-066027:4Canonical exit: 20 Feb 2007 (T+90)
- 400 shares@ US$1.30Common stockSEC:0001181431-06-066027:5Canonical exit: 25 Feb 2007 (T+90)
- 3,000 shares@ US$1.30Common stockSEC:0001181431-06-066027:6Canonical exit: 25 Feb 2007 (T+90)
- 600 shares@ US$1.30Common stockSEC:0001181431-06-066027:7Canonical exit: 25 Feb 2007 (T+90)
- 4,600 shares@ US$1.30Common stockSEC:0001181431-06-066027:9Canonical exit: 25 Feb 2007 (T+90)
- 5,100 shares@ US$1.29Common stockSEC:0001181431-06-066027:10Canonical exit: 25 Feb 2007 (T+90)
- 100 shares@ US$1.45Common StockSEC:0001181431-06-050579:0Canonical exit: 26 Nov 2006 (T+90)
- 900 shares@ US$1.50Common StockSEC:0001181431-06-050579:1Canonical exit: 26 Nov 2006 (T+90)
12 of 12 declarations
About EP Medsystems Inc
EP Medsystems Inc is a company listed on the XNAS market, specializing in the development of medical technologies. It focuses on innovative solutions for the diagnosis and treatment of cardiovascular diseases.
